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INTRODUCTION
Off-pump coronary artery bypass graft (OPCAB) surgery
is now universally performed as an operative treatment of
ischemic heart disease. Hemodynamic derangements ranging
from mild to moderate hypotension to circulatory collapse
can be induced by heart displacement to expose the target
vessels for anastomosis. Several investigators have demon-
strated that biventricular mechanical dysfunction contributes
to the development of these consequences and an impaired
right ventriclular (RV) function plays a pivotal role, especially
during anastomosis of posterior branches (1-5). The patients
with preoperatively reduced RV function could be prone to
become hemodynamically unstable during OPCAB and sup-
portive methods for RV can have beneficial hemodynamic
effects. RV support by means of mechanical assist device was
demonstrated to stabilize the hemodynamic profiles during
heart displacements in an animal model (4). However, instal-
lation of such device may not be so feasible in patients with
respect to the invasiveness and cost-effectiveness of the pro-
cedure. 
Milrinone, phosphodiesterase III inhibitor, has been known
to be an excellent inotropic agent with less myocardial O2con-
sumption than other sympathomimetics (6, 7) and to improve
RV function and reduce pulmonary vascular resistance (PVR)
in an animal model of pulmonary hypertension (8). Moreover,
pharmacologic support with milrinone was also associated
with an improved hemodynamic profile in patients under-
going OPCAB (9).
The aim of this investigation was to evaluate the effect of
continuous milrinone infusion on hemodynamic profile and
RV function, which were measured continuously with ther-
modilution pulmonary artery (PA) catheter during OPCAB
in patients with reduced RV function.
MATERIALS AND METHODS
Patients’ preparation
After institutional review board approval, this study was
prospectively performed in 50 patients with right ventricu-
lar ejection fraction (RVEF) <35% measured by the thermo-
dilution method and written informed consent was obtained
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The Effect of Milrinone on the Right Ventriclular Function in Patients
with Reduced Right Ventricular Function Undergoing Off-pump 
Coronary Artery Bypass Graft Surgery
This investigation evaluated the effect of continuous milrinone infusion on right ven-
triclular (RV) function during off-pump coronary artery bypass graft (OPCAB) surgery
in patients with reduced RV function. Fifty patients scheduled for OPCAB, with ther-
modilution RV ejection fraction (RVEF) <35% after anesthesia induction, were ran-
domly allocated to either milrinone (0.5  g/kg/min) or control (saline) group. Hemo-
dynamic variables and RV volumetric data measured by thermodilution method were
collected as follows: after anesthesia induction (T1); 10 min after heart displacement
for obtuse marginal artery anastomosis (T2); after pericardial closure (T3). Cardiac
index and heart rate increased and systemic vascular resistance significantly dec-
reased in milrinone group at T2. Initially lower RVEF of milrinone group was even-
tually comparable to control group after milrinone infusion. RVEF did not significantly
change at T2 and T3 in both groups. RV end-diastolic volume in milrinone group
consistently decreased from the baseline at T2 and T3. Continuous infusion of mil-
rinone without a bolus demonstrated potentially beneficial effect on cardiac output
and RV afterload in patients with reduced RV function during OPCAB. However,
aggressive augmentation of intravascular volume seems to be necessary to maxi-
mize the effect of the milrinone in these patients.
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from all patients. No patient with any of the following con-
ditions was included; significant preoperative hepatic or renal
dysfunction; thrombocytopenia or coagulopathy; supraven-
tricular tachyarrhythmias; significant ventricular arrhythmias;
preoperative history of receiving inotropic agents; single coro-
nary artery disease. Originally, 96 patients who had been anti-
cipated to have compromised RV function with elevated RV
systolic pressure (>30 mmHg) measured by preoperative trans-
thoracic echocardiography (10) were planned to be included
in this investigation and randomly allocated to either milri-
none or control group using sealed envelope system. Forty
six patients demonstrated a thermodilution RVEF ≥35%
after induction of anesthesia and were excluded and thus, 50
patients (24 in the control group and 26 in the milrinone
group) were finally enrolled for this study.
Monitoring and anesthetic techniques
The patients were premedicated with intramuscular mor-
phine 0.05-0.1 mg/kg given 1 hr before the induction of anes-
thesia. When the patient arrived in the operating theater, 5-
lead electrocardiogram (ECG) electrodes were attached, and
leads II and V5 with ST segment trend analysis were moni-
tored. Direct arterial pressure monitoring was performed by
20-gauge radial artery cannulation. A thermodilution PA
catheter (Swan-Ganz CCOmbo V CCO/SvO2/CEDV Model
775HF75
�, Edwards Lifesciences, Irvine, CA, U.S.A.) was
placed through the right internal jugular vein. The PA cathe-
ter was interfaced with the monitoring device (Vigilance
�,
Edwards Lifesciences, Irvine, CA, U.S.A.) and the Vigilance
�
monitor was also connected to the ECG signal output port
of the patient monitor (CMS
�, Hewlett-Packard, Andover,
Mass., U.S.A.) with slave cable. 
Anesthesia was induced with midazolam 2, 3 mg, sufen-
tanil 1.5-2  g/kg and rocuronium 0.6 mg/kg. After endo-
tracheal intubation, ventilation was controlled artificially to
maintain an end-tidal CO2 of 4.6-5.3 kPa. Anesthesia was
maintained with continuous infusion of sufentanil 0.2-0.3
g/kg/hr and intermittent inhalation of isoflurane 0.2-0.6%
in medical oxygen/air mixture (FiO2 0.6). Vecuronium 2-4
mg/hr was infused to maintain muscle paralysis. After induc-
tion, isosorbide dinitrate 0.3-0.5  g/kg/min was continuously
infused throughout the operation. Transesophageal echocar-
diography (TEE) probe was inserted and both ventricular
functions were continuously monitored. Central body tem-
perature measured with PA catheter was tried to keep around
36.0℃. An average of 1,000-1,500 mL fluid was administered
intravenously during graft vessel harvesting.
OPCAB techniques
After internal mammary artery dissection, heparin 1 mg/kg
was given to maintain an activated clotting time (ACT) ≥
250 sec during the anastomoses. To elevate the cardiac apex
and expose the lateral wall, 2-cm-wide fabric tape was sutured
to the posterior aspect of the pericardial reflection between
the right and left pulmonary veins. With pericardial tape,
the heart was displaced in various directions and angles along
the target vessel for exposure. Tissue stabilizer (Octopus Tissue
Stabilizing System
�, Medtronic, Minneapolis, MN, U.S.A.)
was applied to immobilize the target coronary territory. Anas-
tomoses had been continuously performed without return-
ing the heart to the neutral position. When the beating heart
was displaced for anastomoses, the patient was placed in a
10-20° head-down tilt position and norepinephrine 0.03-0.05
g/kg/min was given intermittently to maintain the mean
arterial pressure (MAP) ≥60-65 mmHg. In case of left ante-
rior descending (LAD) coronary artery anastomosis, an intra-
coronary shunt (Flo-Thru
�, Synovis Innovations, St. Paul,
MN, U.S.A.) was inserted to maintain downstream coronary
flow but, other coronary branches were snared during anas-
tomoses.
Collection of hemodynamic variables
After the induction of anesthesia, hemodynamic variables
and RV volumetric data were collected as the baseline values
(T1). These variables include heart rate (HR), MAP, mean
pulmonary arterial pressure (MPAP), central venous pressure
(CVP), pulmonary capillary wedge pressure (PCWP), cardiac
index (CI), mixed venous saturation (SvO2), RVEF, stroke
volume index (SVI), systemic and pulmonary vascular resis-
tance indices (SVRI and PVRI, respectively), and RV end-dias-
tolic and end-systolic volume indices (RVEDVI and RVESVI,
respectively) which are displayed, calculated and indexed by
the Vigilance
� monitor. With these values, right ventricular
stroke work index (RVSWI) was calculated. After sternotomy,
infusion of milrinone 0.5  g/min/kg (milrinone group) or the
equivalent volume of saline (control group) was started and
maintained throughout the OPCAB procedures. Nurses un-
concerned in this study prepared solutions, and surgeons and
anesthesiologists involved in this study were not aware of the
patient’s group until the end of the study. The variables were
recorded 10 min after the displacement and immobilization
of the heart with tissue stabilizer for obtuse marginal artery
(OM) anastomosis (T2) and after pericardial closure (T3). 
Statistic analysis
Values are expressed as the number of patients for discrete
variables or mean±SD for continuous variables. Differences
of discrete variables between the two groups were evaluated
by  2-test. Independent sample t-tests were performed to com-
pare the continuous variables between the two groups at each
time point. The changes of the variables from T1 within each
group were evaluated by paired t-tests. A p<0.05 was con-
sidered statistically significant. To prevent increasing type I
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for multiple comparisons was performed where appropriate.
Statistical software package running on a personal computer
(SPSS 11.0, SPSS Inc., Chicago, IL, U.S.A.) was used for sta-
tistical analyses.
RESULTS
Demographic data
The two groups were not significantly different in the pa-
tients’ characteristics (Table 1). All patients enrolled in this
investigation successfully underwent OPCAB without emer-
gent conversion to cardiopulmonary bypass and inotropic
support other than milrinone. 
Comparisons of the variables between the two groups
Alterations of hemodynamic variables and RV volumetric
data during OPCAB procedures are shown in Table 2 and 3,
respectively. After the induction of anesthesia (T1), the two
groups were comparable in the whole variables, except that
RVEF was lower in the milrinone group (p=0.015). CI and
HR were higher and SVRI was lower in the milrinone group
than the control group at T2 (p=0.013, 0.011 and 0.001, res-
pectively) and T3 (p=0.009, 0.016 and 0.004, respectively).
Remaining variables were comparable between the two groups
at T2 and T3. The amounts of intravenous fluid infused, blood
products transfused and the dose of norepinephrine infused
during the surgery were comparable between the groups. 
Comparisons of the variables within each group
CI reduced at T2 compared to T1 in control group, but it
was comparable at T2 and increased at T3 from T1 in mil-
rinone group. SvO2 and SVI reduced in both groups at T2
compared to values at T1. MAP was lower in milrinone group
at T2 and MPAP was higher in control group compared to
values at T1. HR increased in milrinone group at T2 and in
both groups at T3 compared to values at T1. SVRI and PVRI
increased in control group at T2, but reduced in milrinone
Control
(n=26)
Milrinone
(n=24)
Sex (Male/Female) 20/6 20/4
Age (yr) 62±86 3 ±8
Weight (kg) 66±10 69±11
Height (cm) 163±9 165±8
BSA (m
2) 1.71±0.16 1.76±0.16
Preoperative EF (%) 57±85 0 ±17
Co-morbid factors
DM 10 10
Hypertension 13 16
Preoperative medication
Nitrates 5 5
Ca
++ blocker 15 11
-blocker 0 0
Digoxin 0 1
-blockers 17 13
ACEI 11 15
Diuretics 6 6
Coronary lesions
Left main 7 9
LAD 23 22
LCx 21 20
RCA 21 22
Graft Number 3±13 ±1
Table 1. Patients’ characteristics
Data are expressed as number of patients or mean±SD. 
BSA, body surface area; EF, ejection fraction; DM, diabetes mellitus;
Ca
++ blockers, calcium channel blockers; ACEIs, angiotensin-converting
enzyme inhibitors; LAD, left anterior descending coronary artery; LCx,
left circumflex artery; RCA, right coronary artery.
T1
Control Milrinone
T2
Control Milrinone
T3
Control Milrinone
CI (L/min/m
2) 2.9±0.7 2.6±0.4 2.3±0.4
� 2.6±0.6* 2.9±0.6 3.3±0.6*
,�
SvO2 (%) 80±57 7 ±67 0 ±6
� 72±6
� 77±67 8 ±6
MAP (mmHg) 80±10 82±11 79±97 3 ±7
� 81±11 78±11
CVP (mmHg) 9±21 0 ±41 0 ±39 ±29 ±29 ±2
PCWP (mmHg) 13±41 6 ±51 5 ±41 4 ±31 4 ±41 4 ±5
MPAP (mmHg) 18±42 1 ±62 1 ±5
� 19±41 9 ±42 1 ±6
HR (beat/min) 64±11 67±12 69±11 79±12*
,� 74±13
� 83±11*
,�
SVI (mL/m
2/ beat) 43±83 9 ±93 4 ±5
� 32±5
� 40±10 41±8
SVRI (dynes∙s/cm
5/m
2) 1,207±309 1,307±350 1,459±307
� 1,138±248* 1,212±271 981±248*
,�
PVRI (dynes∙s/cm
5/m
2)8 7 ±38 104±40 130±57
� 98±31 85±40 80±30
�
Table 2. Alterations of hemodynamic variables during OPCAB
Data are expressed as mean±SD. *p<0.05, compared to Control; 
�
p<0.05, compared to T1. 
OPCAB, off-pump coronary artery bypass graft surgery; T1, after induction of anesthesia; T2, during obtuse marginal artery anastomosis; T3, after peri-
cardial closure; CI, cardiac index; SvO2, mixed venous oxygen saturation; MAP, mean arterial pressure; CVP, central venous pressure; PCWP, pulmonary
capillary wedge pressure; MPAP, mean pulmonary arterial pressure; HR, heart rate; SVI, stroke volume index; SVRI, systemic vascular resistance index;
PVRI, pulmonary vascular resistance index. Milrinone Effect on RV Function in OPCAB 857
group at T3 compared to values at T1. RVEF significantly
increased in milrinone group at T2 and T3 compared to val-
ues at T1. RVSWI demonstrated no significant changes thro-
ughout the procedures in each group. RVESVI and RVED-
VI decreased in control group at T2 and in milrinone group
at T2 and T3 compared to values at T1. 
During the procedures, no significant change was observed
in ST segment analysis or cardiac rhythm. No newly developed
regional wall motion abnormality and valvular insufficiency
were seen on TEE during and after OPCAB procedures. 
DISCUSSION
In the patients with reduced RV function, continuous infu-
sion of milrinone during OPCAB improved CI and RVEF
measured by thermodilution method. In regard to the RVEF,
however, definite improvement over the control group was not
observed in the milrinone group and it seemed to have result-
ed from inadequate preload augmentation.
Several investigations on animals and patients had revealed
that RV dysfunction from mechanical compression was an
important cause of the hemodynamic instability during OP-
CAB (1-5). The degree of heart displacement is often inten-
sified when the vessels on the posterior aspect (e.g. OM artery)
are exposed. 
Milrinone, a well-known inodilator, had been demonstrated
to decrease PVR and to improve RV function in both animal
and human investigations (6-9, 11, 12). Therefore, milrinone
was supposed to exert beneficial effects on RV hemodynamics
in patients undergoing OPCAB in this study. Since the thera-
peutic responses to intravenous milrinone had been reported
to partly depend on the pre-treatment hemodynamic status
(13), patients with thermodilution RVEF <35% were selected
and the hemodynamic variables were measured during OM
anastomosis. Previously it was reported that RVEF and CI
were reduced during OM anastomosis and the increase in RV
afterload was discussed as the possible cause (14).
In this study, milrinone was obviously demonstrated to
improve cardiac output during OM anastomosis as well as
after completion of coronary anastomoses. Milrinone prevent-
ed PVRI increment that occurred in the control group dur-
ing OM anastomosis and even reduced PVRI below the base-
line value after pericardial closure. As RVEF is inversely cor-
related with RV afterload (15), RV function was expected to
be improved in concordance with reduced RV afterload with
milrinone. In fact, RVEF, which was significantly lower in
the milrinone group than in the control group at baseline,
increased to be comparable with that in the control group
after milrinone infusion. Milrinone, however, failed to improve
RVEF on that of the control group in this study and it was
likely to be attributed to following factors. Firstly, the inad-
equate augmentation of RV preload in the milrinone group
might contribute to the result. In spite of the relatively large
amount of fluid administered and head-down tilt position,
RVEDVI consistently reduced from the baseline after milri-
none infusion. This, as well as the increased CO in the mil-
rinone group, is presumed to be the result of the uncompen-
sated vasodilatory effect of milrinone. Preload reduction would
also be complicated with administration of nitrate agents with
additive vasorelaxation effect (16). Given normal or near-nor-
mal RV afterload, preload is the determinant for the RV per-
formance (17). Milrinone has been demonstrated to have ben-
eficial hemodynamic effects only in heart failure patients with
an adequate preload (18). Therefore, maintenance of sufficient
intravascular volume seems to be crucial for beneficial effect
of milrinone on RV function during OPCAB. Secondly, Grun-
deman et al. reported that RV dysfunction and concomitant
hemodynamic instability are due to direct compression of the
RV during coronary artery anastomosis (2). Thus, mechanical
compression of the RV during anastomosis might be another
limitation for milrinone to exert significant effect on RV func-
tion. 
In this study, milrinone increased CI and reduced SVR,
which might be associated with improved left heart func-
tion. Since left and right heart functions are closely related,
improved left ventricular function with milrinone could affect
RV function and the result of this study.
The thermodilution PA catheter used in the current inves-
tigation continuously measured RVEF and volumetric para-
meters. RVEF values measured by this catheter were approved
to have significant reproducibility and correlation with other
T1
Control Milrinone
T2
Control Milrinone
T3
Control Milrinone
RVEF (%) 30±22 7 ±4* 30±63 1 ±6
� 30±53 3 ±7
�
RVSWI (g∙m/m
2/beat) 5.4±1.7 6.1±3.1 5.1±2.1 4.5±1.6 5.7±1.6 6.3±2.5
RVESVI (mL/m
2) 101±21 105±16 84±24
� 74±14
� 95±25 86±26
�
RVEDVI (mL/m
2) 143±27 144±18 118±26
� 106±13
� 135±32 126±31
�
Table 3. Alterations of RV volumetric data during OPCAB
Data are expressed as mean±SD. *p<0.05, compared to Control; 
�
p<0.05, compared to T1. 
OPCAB, off-pump coronary artery bypass graft surgery; T1, after induction of anesthesia; T2, during obtuse marginal artery anastomosis; T3, after peri-
cardial closure; RVEF, right ventricular ejection fraction; RVSWI, right ventricular stroke work index; RVESVI, right ventricular end-systolic volume index;
RVEDVI, right ventricular end-diastolic volume index. 
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methods (19, 20). However, this parameter has limitations
in monitoring RV function because RVEF is load-dependent.
Significant alterations in RV preload would interfere with the
efficacy of RVEF measured with the thermodilution catheter
to evaluate RV function. TEE has been known to be an effec-
tive monitoring tool for wall motion and volume status in
cardiac patients, (21) and employing additional echocardio-
graphic indices could be more helpful to delineate the change
of RV function with milrinone infusion. Monitoring RV func-
tion with TEE, however, during distal coronary anastomosis
in every patient would be impossible because of displacement
and elevation of the heart during that period.
To reduce the risk of hypotension, milrinone was infused
without a bolus dose (9). Continuous infusion without a bolus
was reported to demonstrate hemodynamic effects within 30
min from the start of infusion (22). In the present study, it
took more than an hour to begin the coronary anastomosis
after starting milrinone infusion and significant changes in
hemodynamic parameters including CI, HR, SVRI and PVRI
could be a proof of therapeutic plasma concentration of mil-
rinone.
In conclusion, continuous infusion of milrinone was demon-
strated to improve CI and RV afterload and have potentially
beneficial effect on RV function in the patients with reduced
RV function during OPCAB. Adequate augmentation of in-
travascular volume could be helpful to accomplish definite
hemodynamic effect of milrinone administration in these pati-
ents.
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